These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36111901)

  • 1. A brief introduction to chemical proteomics for target deconvolution.
    Dong ZC; Wang Y; Yang F; Wan F
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6014-6026. PubMed ID: 36111901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent advances in protein precipitation-based methods for drug-target screening].
    Liu T; Qin WJ; Yang HJ
    Se Pu; 2024 Jul; 42(7):613-622. PubMed ID: 38966970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target deconvolution from phenotype-based drug discovery by using chemical proteomics approaches.
    Kubota K; Funabashi M; Ogura Y
    Biochim Biophys Acta Proteins Proteom; 2019 Jan; 1867(1):22-27. PubMed ID: 30392561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemistry-based functional proteomics for drug target deconvolution.
    Wang K; Yang T; Wu Q; Zhao X; Nice EC; Huang C
    Expert Rev Proteomics; 2012 Jun; 9(3):293-310. PubMed ID: 22809208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome Integral Solubility Alteration (PISA) Assay in Mammalian Cells for Deep, High-Confidence, and High-Throughput Target Deconvolution.
    Zhang X; Lytovchenko O; Lundström SL; Zubarev RA; Gaetani M
    Bio Protoc; 2022 Nov; 12(22):. PubMed ID: 36532690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target deconvolution techniques in modern phenotypic profiling.
    Lee J; Bogyo M
    Curr Opin Chem Biol; 2013 Feb; 17(1):118-26. PubMed ID: 23337810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome-Wide Deconvolution of Drug Targets and Binding Sites by Lysine Reactivity Profiling.
    Ruan C; Zhou J; Li Z; Li K; Fang Z; Zhang X; Ye M
    Anal Chem; 2022 Feb; 94(7):3352-3359. PubMed ID: 35147412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry-based Cellular Thermal Shift Assay (CETSA®) for target deconvolution in phenotypic drug discovery.
    Friman T
    Bioorg Med Chem; 2020 Jan; 28(1):115174. PubMed ID: 31767405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protein binding partners of small molecules using label-free methods.
    Saxena C
    Expert Opin Drug Discov; 2016 Oct; 11(10):1017-25. PubMed ID: 27554241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target deconvolution with matrix-augmented pooling strategy reveals cell-specific drug-protein interactions.
    Ji H; Lu X; Zhao S; Wang Q; Liao B; Bauer LG; Huber KVM; Luo R; Tian R; Tan CSH
    Cell Chem Biol; 2023 Nov; 30(11):1478-1487.e7. PubMed ID: 37652024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical proteomics: terra incognita for novel drug target profiling.
    Huang F; Zhang B; Zhou S; Zhao X; Bian C; Wei Y
    Chin J Cancer; 2012 Nov; 31(11):507-18. PubMed ID: 22640626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive chemical proteomics for target deconvolution of the redox active drug auranofin.
    Saei AA; Gullberg H; Sabatier P; Beusch CM; Johansson K; Lundgren B; Arvidsson PI; Arnér ESJ; Zubarev RA
    Redox Biol; 2020 May; 32():101491. PubMed ID: 32199331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesopore-assisted profiling strategies in clinical proteomics for drug/target discovery.
    Savino R; Terracciano R
    Drug Discov Today; 2012 Feb; 17(3-4):143-52. PubMed ID: 22016086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery.
    Jung HJ; Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1627-41. PubMed ID: 26040984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability-based approaches in chemoproteomics.
    George AL; Dueñas ME; Marín-Rubio JL; Trost M
    Expert Rev Mol Med; 2024 Apr; 26():e6. PubMed ID: 38604802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical proteomics and its impact on the drug discovery process.
    Miao Q; Zhang CC; Kast J
    Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of Small Molecules by Chemical Proteomics.
    Huber KVM; Superti-Furga G
    Methods Mol Biol; 2016; 1394():211-218. PubMed ID: 26700051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solvent-Induced Protein Precipitation for Drug Target Discovery.
    Zhang X; Hu L; Ye M
    Methods Mol Biol; 2023; 2554():35-45. PubMed ID: 36178619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immuno-chemo-proteomics method for drug target deconvolution.
    Saxena C; Zhen E; Higgs RE; Hale JE
    J Proteome Res; 2008 Aug; 7(8):3490-7. PubMed ID: 18590316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target identification of small molecules based on chemical biology approaches.
    Futamura Y; Muroi M; Osada H
    Mol Biosyst; 2013 May; 9(5):897-914. PubMed ID: 23354001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.